Sandy Spring Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $194K | Sell |
1,730
-145
| -8% | -$15K | 0.01% | 369 |
|
|
2024
Q4 | $173K | Sell |
1,875
-280
| -13% | -$25.2K | 0.01% | 391 |
|
|
2024
Q3 | $181K | Sell |
2,155
-390
| -15% | -$29.8K | 0.01% | 391 |
|
|
2024
Q2 | $175K | Sell |
2,545
-334
| -12% | -$22.3K | 0.01% | 383 |
|
|
2024
Q1 | $211K | Sell |
2,879
-629
| -18% | -$48.4K | 0.01% | 364 |
|
|
2023
Q4 | $284K | Sell |
3,508
-221
| -6% | -$17.2K | 0.01% | 322 |
|
|
2023
Q3 | $279K | Sell |
3,729
-2,836
| -43% | -$218K | 0.02% | 310 |
|
|
2023
Q2 | $506K | Sell |
6,565
-872
| -12% | -$69.5K | 0.03% | 260 |
|
|
2023
Q1 | $617K | Buy |
7,437
+358
| +5% | +$29.7K | 0.04% | 242 |
|
|
2022
Q4 | $608K | Sell |
7,079
-150
| -2% | -$11.9K | 0.04% | 244 |
|
|
2022
Q3 | $445K | Sell |
7,229
-77
| -1% | -$4.86K | 0.03% | 253 |
|
|
2022
Q2 | $452K | Sell |
7,306
-144
| -2% | -$8.92K | 0.03% | 253 |
|
|
2022
Q1 | $443K | Sell |
7,450
-722
| -9% | -$46.2K | 0.02% | 259 |
|
|
2021
Q4 | $594K | Buy |
8,172
+496
| +6% | +$34.2K | 0.03% | 252 |
|
|
2021
Q3 | $536K | Sell |
7,676
-374
| -5% | -$26.3K | 0.03% | 253 |
|
|
2021
Q2 | $554K | Sell |
8,050
-30
| -0.4% | -$2K | 0.03% | 245 |
|
|
2021
Q1 | $522K | Sell |
8,080
-365
| -4% | -$23.5K | 0.03% | 245 |
|
|
2020
Q4 | $492K | Buy |
8,445
+272
| +3% | +$16.4K | 0.03% | 245 |
|
|
2020
Q3 | $516K | Sell |
8,173
-231
| -3% | -$16K | 0.04% | 227 |
|
|
2020
Q2 | $647K | Sell |
8,404
-187
| -2% | -$14.3K | 0.05% | 209 |
|
|
2020
Q1 | $643K | Sell |
8,591
-1,453
| -14% | -$100K | 0.06% | 197 |
|
|
2019
Q4 | $653K | Sell |
10,044
-1,018
| -9% | -$66.3K | 0.05% | 216 |
|
|
2019
Q3 | $701K | Sell |
11,062
-7,233
| -40% | -$473K | 0.05% | 210 |
|
|
2019
Q2 | $1.24M | Sell |
18,295
-4,218
| -19% | -$277K | 0.1% | 177 |
|
|
2019
Q1 | $1.46M | Sell |
22,513
-3,460
| -13% | -$230K | 0.12% | 160 |
|
|
2018
Q4 | $1.63M | Sell |
25,973
-12,185
| -32% | -$852K | 0.16% | 145 |
|
|
2018
Q3 | $2.95M | Sell |
38,158
-1,305
| -3% | -$98.6K | 0.24% | 104 |
|
|
2018
Q2 | $2.79M | Sell |
39,463
-3,549
| -8% | -$251K | 0.24% | 107 |
|
|
2018
Q1 | $3.24M | Buy |
43,012
+2,392
| +6% | +$190K | 0.29% | 91 |
|
|
2017
Q4 | $2.91M | Sell |
40,620
-2,614
| -6% | -$199K | 0.27% | 100 |
|
|
2017
Q3 | $3.5M | Buy |
43,234
+2,146
| +5% | +$164K | 0.34% | 78 |
|
|
2017
Q2 | $2.91M | Sell |
41,088
-5,398
| -12% | -$359K | 0.29% | 92 |
|
|
2017
Q1 | $3.16M | Buy |
46,486
+963
| +2% | +$67.7K | 0.31% | 82 |
|
|
2016
Q4 | $3.26M | Buy |
45,523
+7,003
| +18% | +$521K | 0.34% | 73 |
|
|
2016
Q3 | $3.05M | Buy |
38,520
+1,704
| +5% | +$138K | 0.33% | 79 |
|
|
2016
Q2 | $3.07M | Sell |
36,816
-635
| -2% | -$56.4K | 0.35% | 72 |
|
|
2016
Q1 | $3.44M | Buy |
37,451
+1,991
| +6% | +$180K | 0.39% | 68 |
|
|
2015
Q4 | $3.59M | Buy |
35,460
+930
| +3% | +$96.8K | 0.42% | 69 |
|
|
2015
Q3 | $3.39M | Buy |
34,530
+1,207
| +4% | +$134K | 0.42% | 67 |
|
|
2015
Q2 | $3.9M | Buy |
33,323
+310
| +0.9% | +$33.9K | 0.44% | 66 |
|
|
2015
Q1 | $3.24M | Buy |
33,013
+4,662
| +16% | +$473K | 0.38% | 74 |
|
|
2014
Q4 | $2.67M | Buy |
28,351
+1,115
| +4% | +$115K | 0.32% | 92 |
|
|
2014
Q3 | $2.9M | Buy |
27,236
+77
| +0.3% | +$7.54K | 0.36% | 85 |
|
|
2014
Q2 | $2.25M | Sell |
27,159
-9,299
| -26% | -$724K | 0.28% | 101 |
|
|
2014
Q1 | $2.58M | Buy |
36,458
+4,598
| +14% | +$361K | 0.4% | 78 |
|
|
2013
Q4 | $2.39M | Sell |
31,860
-3,549
| -10% | -$247K | 0.34% | 89 |
|
|
2013
Q3 | $2.23M | Sell |
35,409
-2,360
| -6% | -$141K | 0.33% | 87 |
|
|
2013
Q2 | $1.94M | Buy |
+37,769
| New | +$1.97M | 0.3% | 93 |
|
Other funds holding GILD
Sandy Spring Bank's GILD Position: Q1 2025 in Review
Sandy Spring Bank reduced its Gilead Sciences (GILD) stake by 7.7% in Q1 2025, selling an estimated $15K and leaving 1,730 shares worth $194K. The position accounts for 0.01% of the portfolio, ranked #369.
Sandy Spring Bank first reported a position in GILD in Q2 2013 and has held it in 48 quarters since. The position peaked at $3.9M in Q2 2015. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Sandy Spring Bank held 1,730 shares of Gilead Sciences worth $194K as of Q1 2025.
- Sandy Spring Bank sold 145 Gilead Sciences shares in Q1 2025, an estimated $15K.
- Gilead Sciences made up 0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #369 holding.
- Sandy Spring Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 48 quarters since.
- Sandy Spring Bank's Gilead Sciences position peaked at $3.9M in Q2 2015.
- 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.